ESC Premium Access

Comparing the real-world and clinical trial bleeding rates associated with oral anticoagulation treatment for atrial fibrillation

Congress Presentation

About the speaker

Doctor Ying Gue

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
0 follower

8 more presentations in this session

Switching from warfarin to a DOAC in frail elderly asian patients with atrial fibrillation: a nationwide population-based study

Speaker: Doctor Y. Go (Seoul, KR)

Thumbnail

Drug interactions in incident NOACs users and risk of bleeding

Speaker: Doctor M. Amadori (Bologna, IT)

Thumbnail

Impact of real-world off-label dose of Apixaban on long-term clinical outcomes in patients with atrial fibrillation and chronic kidney disease

Speaker: Doctor H. Shin (Busan, KR)

Thumbnail

Resumption of anticoagulation therapy among Non-Valvular Atrial Fibrillation (NVAF) patients with prior intracranial haemorrhage

Speaker: Doctor W. Sun (Shatin, HK)

Thumbnail

The incidence of death and risk factors for mortality following major bleeding in patients anticoagulated with factor Xa inhibitors: an observational study in the UK clinical setting (AXIOM UK)

Speaker: Doctor A. Cohen (London, GB)

Thumbnail

Access the full session

Clinical decision-making about oral anticoagulant therapy in atrial fibrillation

Speakers: Doctor Y. Gue, Doctor Y. Go, Doctor M. Amadori, Doctor H. Shin, Doctor W. Sun...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations